Broadfin Capital’s Alkermes ALKS Stock Holding History

Broadfin Capital’s Portfolio ALKS Stock Details ALKS Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2019 Q4	$4.08M	Buy	+200,000	New	+$3.98M	0.55%	33

Other funds holding ALKS

T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return

Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

Primecap Management Pasadena, California $127B AUM 44.11% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

CCM

Camber Capital Management Boston, Massachusetts $1.07B AUM 8.19% 1-Year Est. Return

SCM

Sarissa Capital Management Greenwich, Connecticut $158M AUM 103.7% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

Broadfin Capital's ALKS Position: Q4 2019 in Review

Broadfin Capital increased its Alkermes (ALKS) stake by 315% in Q4 2019, buying an estimated $15.6M and bringing the position to 1,033,500 shares worth $21.1M. The position accounts for 2.82% of the portfolio, ranked #9.

Broadfin Capital first reported a position in ALKS in Q2 2013 and has held it in 4 quarters since. 216 funds tracked by Wall St. Rank hold ALKS as of Q4 2019.

Broadfin Capital held 1,033,500 shares of Alkermes worth $21.1M as of Q4 2019.
Broadfin Capital bought 784,500 Alkermes shares in Q4 2019, an estimated $15.6M.
Alkermes made up 2.82% of Broadfin Capital's portfolio in Q4 2019, its #9 holding.
Broadfin Capital first reported a position in Alkermes in Q2 2013 and has held it in 4 quarters since.
216 funds tracked by Wall St. Rank held Alkermes as of Q4 2019.

Based on Broadfin Capital's 13F filing for Q4 2019, filed 14 Feb 2020.